MediXall Group, Inc.
MDXL
$0.0035
$0.00026.06%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -60.17% | 7.28% | 19.82% | 31.47% | -64.44% |
| Total Depreciation and Amortization | 1,992.31% | 0.00% | -71.11% | -86.80% | 1,723.81% |
| Total Amortization of Deferred Charges | -94.55% | 6.29% | 2.72% | 7.10% | 1.86% |
| Total Other Non-Cash Items | -66.67% | 0.00% | 0.00% | -52.52% | 506.10% |
| Change in Net Operating Assets | 863.23% | 59.74% | -77.38% | 179.56% | -70.92% |
| Cash from Operations | 23.68% | 30.63% | 0.89% | 35.85% | 33.37% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -182.35% |
| Total Debt Issued | -20.59% | -35.72% | 4.18% | -24.97% | -36.40% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -90.50% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -20.59% | -35.72% | 3.66% | -27.45% | -33.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.36% | -154.60% | 1,581.82% | 98.48% | 26.55% |
